Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C14H26N4O3 |
Molecular Weight | 298.3812 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C[C@@H](N(C)C(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O
InChI
InChIKey=BXCQMQVEMFYKJC-WDEREUQCSA-N
InChI=1S/C14H26N4O3/c1-9(2)7-11(13(20)17-8-12(15)19)18(3)14(21)10-5-4-6-16-10/h9-11,16H,4-8H2,1-3H3,(H2,15,19)(H,17,20)/t10-,11+/m0/s1
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Trace analysis of the MIF analogue pareptide in blood plasma by high-performance liquid chromatography and short-wavelength excitation fluorometry. | 1979 Aug 21 |
|
Determination of the melanotropin-inhibiting factor analogue pareptide in urine by high-performance liquid chromatography. | 1981 Mar 13 |
|
Pro-Leu-Gly-NH2 and pareptide inhibit development of tolerance to haloperidol catalepsy in the mouse. | 1984 Sep-Oct |
|
Pharmacological activities of the MIF-1 analogues Pro-Leu-Gly, Tyr-Pro-Leu-Gly and pareptide. | 1987 Nov-Dec |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C38149
Created by
admin on Fri Dec 15 16:08:11 GMT 2023 , Edited by admin on Fri Dec 15 16:08:11 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4347
Created by
admin on Fri Dec 15 16:08:11 GMT 2023 , Edited by admin on Fri Dec 15 16:08:11 GMT 2023
|
PRIMARY | |||
|
10086055
Created by
admin on Fri Dec 15 16:08:11 GMT 2023 , Edited by admin on Fri Dec 15 16:08:11 GMT 2023
|
PRIMARY | |||
|
SUB09623MIG
Created by
admin on Fri Dec 15 16:08:11 GMT 2023 , Edited by admin on Fri Dec 15 16:08:11 GMT 2023
|
PRIMARY | |||
|
CHEMBL2111011
Created by
admin on Fri Dec 15 16:08:11 GMT 2023 , Edited by admin on Fri Dec 15 16:08:11 GMT 2023
|
PRIMARY | |||
|
4743XI19RY
Created by
admin on Fri Dec 15 16:08:11 GMT 2023 , Edited by admin on Fri Dec 15 16:08:11 GMT 2023
|
PRIMARY | |||
|
C024569
Created by
admin on Fri Dec 15 16:08:11 GMT 2023 , Edited by admin on Fri Dec 15 16:08:11 GMT 2023
|
PRIMARY | |||
|
4743XI19RY
Created by
admin on Fri Dec 15 16:08:11 GMT 2023 , Edited by admin on Fri Dec 15 16:08:11 GMT 2023
|
PRIMARY | |||
|
61484-38-6
Created by
admin on Fri Dec 15 16:08:11 GMT 2023 , Edited by admin on Fri Dec 15 16:08:11 GMT 2023
|
PRIMARY | |||
|
C66319
Created by
admin on Fri Dec 15 16:08:11 GMT 2023 , Edited by admin on Fri Dec 15 16:08:11 GMT 2023
|
PRIMARY | |||
|
DTXSID50210450
Created by
admin on Fri Dec 15 16:08:11 GMT 2023 , Edited by admin on Fri Dec 15 16:08:11 GMT 2023
|
PRIMARY | |||
|
2619909
Created by
admin on Fri Dec 15 16:08:11 GMT 2023 , Edited by admin on Fri Dec 15 16:08:11 GMT 2023
|
PRIMARY | |||
|
100000082815
Created by
admin on Fri Dec 15 16:08:11 GMT 2023 , Edited by admin on Fri Dec 15 16:08:11 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)